Log In
Print
BCIQ
Print
Print this Print this
 

Anoro, Anoro Ellipta (GSK573719 (umeclidinium bromide)/GSK642444, GSK573719/vilanterol)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionFixed-dose inhaled dry powder formulation of a long-acting muscarinic antagonist (LAMA) and a long-acting adrenergic receptor beta 2 agonist (LABA)
Molecular Target Muscarinic receptor ; Adrenergic receptor beta 2 (ADRB2)
Mechanism of ActionAdrenergic receptor beta 2 (ADRB2) agonist; Muscarinic receptor antagonist
Latest Stage of DevelopmentRegistration
IndicationChronic obstructive pulmonary disease (COPD)
Partner

Theravance Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today